2-232796136-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001103146.3(GIGYF2):c.1554G>A(p.Glu518=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0655 in 1,599,972 control chromosomes in the GnomAD database, including 4,052 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.079 ( 614 hom., cov: 32)
Exomes 𝑓: 0.064 ( 3438 hom. )
Consequence
GIGYF2
NM_001103146.3 synonymous
NM_001103146.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.05
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-232796136-G-A is Benign according to our data. Variant chr2-232796136-G-A is described in ClinVar as [Benign]. Clinvar id is 522283.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232796136-G-A is described in Lovd as [Benign]. Variant chr2-232796136-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=2.05 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.163 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIGYF2 | NM_001103146.3 | c.1554G>A | p.Glu518= | synonymous_variant | 14/29 | ENST00000373563.9 | NP_001096616.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GIGYF2 | ENST00000373563.9 | c.1554G>A | p.Glu518= | synonymous_variant | 14/29 | 1 | NM_001103146.3 | ENSP00000362664 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0793 AC: 12062AN: 152078Hom.: 612 Cov.: 32
GnomAD3 genomes
AF:
AC:
12062
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0708 AC: 17778AN: 251254Hom.: 868 AF XY: 0.0687 AC XY: 9331AN XY: 135802
GnomAD3 exomes
AF:
AC:
17778
AN:
251254
Hom.:
AF XY:
AC XY:
9331
AN XY:
135802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0640 AC: 92693AN: 1447776Hom.: 3438 Cov.: 27 AF XY: 0.0636 AC XY: 45874AN XY: 721214
GnomAD4 exome
AF:
AC:
92693
AN:
1447776
Hom.:
Cov.:
27
AF XY:
AC XY:
45874
AN XY:
721214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0794 AC: 12079AN: 152196Hom.: 614 Cov.: 32 AF XY: 0.0807 AC XY: 6003AN XY: 74402
GnomAD4 genome
AF:
AC:
12079
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
6003
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
341
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Parkinson disease 11, autosomal dominant, susceptibility to Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Apr 21, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Sep 21, 2015 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at